-
Needham & Company LLC Reaffirms "Buy" Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)
Source: Buzz FX / 07 Nov 2024 09:26:16 America/New_York
Needham & Company LLC Reaffirms "Buy" Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD) Written by MarketBeat November 7, 2024 Share Link copied to clipboard. ACADIA Pharmaceuticals ( NASDAQ:ACAD - Get Free Report ) 's stock had its "buy" rat
Read more...